RENAL CANCER STAGE III

RENAL CANCER STAGE III was reported 1841 times

These drug classes are most commonly taken by patients reporting RENAL CANCER STAGE III:

# Drug Count
0 Corticosteroid [EPC] 8
1 Nonsteroidal Anti-inflammatory Drug [EPC] 5
2 Benzodiazepine [EPC] 4
3 Calcium Channel Blocker [EPC] 4
4 Dihydropyridine Calcium Channel Blocker [EPC] 4
5 Interferon beta [EPC] 4
6 Interleukin-4 Receptor alpha Antagonist [EPC] 4
7 Provitamin D2 Compound [EPC] 4
8 Angiotensin 2 Receptor Blocker [EPC] 3
9 HMG-CoA Reductase Inhibitor [EPC] 3
10 Insulin Analog [EPC] 3
11 Interleukin-2 Receptor Blocking Antibody [EPC] 3
12 Interleukin-23 Antagonist [EPC] 3
13 Kinase Inhibitor [EPC] 3
14 Proton Pump Inhibitor [EPC] 3
15 Tumor Necrosis Factor Blocker [EPC] 3
16 Xanthine Oxidase Inhibitor [EPC] 3
17 beta-Adrenergic Blocker [EPC] 3
18 Angiotensin Converting Enzyme Inhibitor [EPC] 2
19 Antimetabolite Immunosuppressant [EPC] 2
20 GLP-1 Receptor Agonist [EPC] 2
21 Histamine-2 Receptor Antagonist [EPC] 2
22 Janus Kinase Inhibitor [EPC] 2
23 Loop Diuretic [EPC] 2
24 Nitrate Vasodilator [EPC] 2
25 Platelet Aggregation Inhibitor [EPC] 2
26 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2
27 Thiazide Diuretic [EPC] 2
28 5-alpha Reductase Inhibitor [EPC] 1
29 Amide Local Anesthetic [EPC] 1
30 Androgen Receptor Inhibitor [EPC] 1
31 Anti-IgE [EPC] 1
32 Anti-epileptic Agent [EPC] 1
33 Antiarrhythmic [EPC] 1
34 Arteriolar Vasodilator [EPC] 1
35 BCL-2 Inhibitor [EPC] 1
36 Barbiturate [EPC] 1
37 CD20-directed Cytolytic Antibody [EPC] 1
38 Calcineurin Inhibitor Immunosuppressant [EPC] 1
39 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1
40 Central Nervous System Stimulant [EPC] 1
41 Complement Inhibitor [EPC] 1
42 Cytochrome P450 3A Inhibitor [EPC] 1
43 Dietary Cholesterol Absorption Inhibitor [EPC] 1
44 Ester Local Anesthetic [EPC] 1
45 Expectorant [EPC] 1
46 Fluoroquinolone Antibacterial [EPC] 1
47 Folate Analog Metabolic Inhibitor [EPC] 1
48 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] 1
49 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
50 Immunoglobulin G [EPC] 1
51 Interleukin-12 Antagonist [EPC] 1
52 Interleukin-17 Receptor A Antagonist [EPC] 1
53 Interleukin-17A Antagonist [EPC] 1
54 Methylxanthine [EPC] 1
55 Mood Stabilizer [EPC] 1
56 Muscle Relaxant [EPC] 1
57 Nitroimidazole Antimicrobial [EPC] 1
58 Non-Standardized Chemical Allergen [EPC] 1
59 Opioid Agonist [EPC] 1
60 Osmotic Laxative [EPC] 1
61 PCSK9 Inhibitor [EPC] 1
62 Parathyroid Hormone Analog [EPC] 1
63 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
64 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
65 Prostaglandin Analog [EPC] 1
66 RANK Ligand Inhibitor [EPC] 1
67 RNA Synthetase Inhibitor Antibacterial [EPC] 1
68 Selective T Cell Costimulation Modulator [EPC] 1
69 Serotonin Reuptake Inhibitor [EPC] 1
70 Sulfonylurea [EPC] 1
71 Sympathomimetic-like Agent [EPC] 1
72 Tetracycline-class Drug [EPC] 1
73 Thiazide-like Diuretic [EPC] 1